{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:56:05Z","timestamp":1790812565392,"version":"4.1.0"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:sec>\n            <jats:title>Objectives:<\/jats:title>\n            <jats:p>To perform a comprehensive description of the epidemiology of <jats:italic toggle=\"yes\">Streptococcus pyogenes<\/jats:italic> invasive disease in the pediatric population in 2 regions of Spain (Catalonia and Gipuzkoa) through 12 years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>All <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic> isolates causing invasive disease in pediatric patients between 2005 and 2016 were included. The <jats:italic toggle=\"yes\">emm<\/jats:italic>-type and the presence of 13 exotoxin genes (<jats:italic toggle=\"yes\">speA<\/jats:italic>, <jats:italic toggle=\"yes\">speB<\/jats:italic>, <jats:italic toggle=\"yes\">speC<\/jats:italic>, <jats:italic toggle=\"yes\">speF<\/jats:italic>, <jats:italic toggle=\"yes\">speG<\/jats:italic>, <jats:italic toggle=\"yes\">speH<\/jats:italic>, <jats:italic toggle=\"yes\">speI<\/jats:italic>, <jats:italic toggle=\"yes\">speJ<\/jats:italic>, <jats:italic toggle=\"yes\">speK<\/jats:italic>, <jats:italic toggle=\"yes\">speL<\/jats:italic>, <jats:italic toggle=\"yes\">speM<\/jats:italic>, <jats:italic toggle=\"yes\">smeZ<\/jats:italic>, <jats:italic toggle=\"yes\">ssa<\/jats:italic> and <jats:italic toggle=\"yes\">slo<\/jats:italic>) were determined in all 93 available isolates and the Multi Locus Sequece Typing in 10% of isolates of each different <jats:italic toggle=\"yes\">emm<\/jats:italic>-type.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Overall, 103 cases of <jats:italic toggle=\"yes\">S. pyogenes<\/jats:italic> invasive infections were detected: 77 in Catalonia and 26 in Gipuzkoa, being 50.5% females. The incidence rate per 100,000 children was 2.5 for Gipuzkoa and 2.6 for Catalonia, with no significant temporal trends. The median age was 30 months. The most frequent clinical presentations were: pneumonia (26.2%), bacteremia\/sepsis (23.3%), septic arthritis\/osteomyelitis (22.3%), cellulitis\/mastoiditis (12.6%) and meningitis (6.8%). Eight children developed streptococcal toxic shock syndrome. Nine cases were preceded by varicella infection. The associated mortality rate was 3.9%. Three isolates were resistant to erythromycin, being one of them also resistant to clindamycin and 4 isolates were resistant to levofloxacine. Forteen different <jats:italic toggle=\"yes\">emm<\/jats:italic>-types were detected being <jats:italic toggle=\"yes\">emm<\/jats:italic>1\/ST28 (40.9%) the most frequent clone in both regions followed by <jats:italic toggle=\"yes\">emm<\/jats:italic>12\/ST36-ST242, e<jats:italic toggle=\"yes\">mm<\/jats:italic>6\/ST382, <jats:italic toggle=\"yes\">emm<\/jats:italic>3\/ST15, <jats:italic toggle=\"yes\">emm<\/jats:italic>75\/ST150 and <jats:italic toggle=\"yes\">emm<\/jats:italic>4\/ST38-39. <jats:italic toggle=\"yes\">speA<\/jats:italic> gene was only detected in <jats:italic toggle=\"yes\">emm<\/jats:italic>1 and <jats:italic toggle=\"yes\">emm<\/jats:italic>3 isolates. Eight exotoxins were enough to assign an <jats:italic toggle=\"yes\">emm<\/jats:italic>-type with a very high degree of accuracy (95%). The 30-valent vaccine would include 96.8% of isolates.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000002471","type":"journal-article","created":{"date-parts":[[2019,11,18]],"date-time":"2019-11-18T19:32:45Z","timestamp":1574105565000},"page":"1168-1172","source":"Crossref","is-referenced-by-count":15,"title":["Molecular Characterization of Streptococcus pyogenes Causing Invasive Disease in Pediatric Population in Spain A 12-year Study"],"prefix":"10.1097","volume":"38","author":[{"given":"Viviana","family":"S\u00e1nchez-Encinales","sequence":"first","affiliation":[{"name":"Microbiology Department, Donostia University Hospital-Biodonostia Health Research Institute, Donostia-San Sebastian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Ludwig","sequence":"additional","affiliation":[{"name":"Molecular Microbiology Department, Institut de Recerca Sant Joan de D\u00e9u, Sant Joan de D\u00e9u University Hospital, Barcelona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Tamayo","sequence":"additional","affiliation":[{"name":"Department of Immunology, Microbiology and Parasitology, Faculty of Medicine, University of the Basque Country (UPV\/EHU), Leioa, Bizkaia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Maria","family":"Garc\u00eda-Arenzana","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital-Biodonostia Health Research Institute, Donostia-San Sebastian"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mu\u00f1oz-Almagro","sequence":"additional","affiliation":[{"name":"Molecular Microbiology Department, Institut de Recerca Sant Joan de D\u00e9u, Sant Joan de D\u00e9u University Hospital, Barcelona"},{"name":"CIBER de Epidemiolog\u00eda y Salud P\u00fablica (CIBERESP), Instituto de Salud Carlos III, Madrid"},{"name":"School of Medicine, Universitat Internacional de Catalunya, Barcelona, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milagrosa","family":"Montes","sequence":"additional","affiliation":[{"name":"Microbiology Department, Donostia University Hospital-Biodonostia Health Research Institute, Donostia-San Sebastian"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20240429","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012.","volume":"63","author":"Nelson","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R2-20240429","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.2165\/11634180-000000000-00000","article-title":"Invasive group A streptococcal disease: epidemiology, pathogenesis and management.","volume":"72","author":"Steer","year":"2012","journal-title":"Drugs"},{"key":"R3-20240429","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2807\/1560-7917.ES2014.19.17.20784","article-title":"Invasive infections due to Streptococcus pyogenes: seasonal variation of severity and clinical characteristics, Iceland, 1975 to 2012.","volume":"19","author":"Olafsdottir","year":"2014","journal-title":"Euro Surveill"},{"key":"R4-20240429","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s10096-016-2704-y","article-title":"Epidemiology of invasive group A streptococcal infections in Norway 2010-2014: a retrospective cohort study.","volume":"35","author":"Naseer","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R5-20240429","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jinf.2018.05.010","article-title":"Epidemiology of an upsurge of invasive group A streptococcal infections in Ireland, 2012-2015.","volume":"77","author":"Meehan","year":"2018","journal-title":"J Infect"},{"key":"R6-20240429","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00431-012-1694-8","article-title":"Current insights in invasive group A streptococcal infections in pediatrics.","volume":"171","author":"Filleron","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R7-20240429","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s10096-011-1226-x","article-title":"Epidemiological and molecular analysis of Streptococcus pyogenes isolates causing invasive disease in Spain (1998-2009): comparison with non-invasive isolates.","volume":"30","author":"Montes","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R8-20240429","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/cid\/civ793","article-title":"Clinical and microbiological characteristics of invasive group A streptococcal infections before and after implementation of a universal varicella vaccine program.","volume":"62","author":"Fr\u00e8re","year":"2016","journal-title":"Clin Infect Dis"},{"key":"R9-20240429","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s10096-009-0854-x","article-title":"Invasive group A streptococcal infection in children: clinical manifestations and molecular characterization in a French pediatric tertiary care center.","volume":"29","author":"Henriet","year":"2010","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R10-20240429","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/INF.0000000000000945","article-title":"Invasive group A streptococcal infections in children: a nationwide survey in Finland.","volume":"35","author":"Tapiainen","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R11-20240429","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1128\/JCM.02155-08","article-title":"Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe.","volume":"47","author":"Luca-Harari","year":"2009","journal-title":"J Clin Microbiol"},{"key":"R12-20240429","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1017\/S0950268813001386","article-title":"Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections.","volume":"142","author":"Zachariadou","year":"2014","journal-title":"Epidemiol Infect"},{"key":"R13-20240429","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1128\/JCM.00070-11","article-title":"Epidemiology of invasive Streptococcus pyogenes infections in France in 2007.","volume":"49","author":"Lepoutre","year":"2011","journal-title":"J Clin Microbiol"},{"key":"R14-20240429","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1093\/jpids\/pix099","article-title":"Prospective surveillance of pediatric invasive group A streptococcus infection.","volume":"8","author":"Ching","year":"2019","journal-title":"J Pediatric Infect Dis Soc"},{"key":"R15-20240429","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.eimc.2017.06.005","article-title":"Invasive disease by Streptococcus pyogenes: patients hospitalized for 6 years.","volume":"36","author":"Arias-Constant\u00ed","year":"2018","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"R16-20240429","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.anpedi.2017.02.011","article-title":"Streptococcus pyogenes infection in paediatrics: from pharyngotonsillitis to invasive infections.","volume":"88","author":"Espadas Maci\u00e1","year":"2018","journal-title":"An Pediatr (Barc)"},{"key":"R17-20240429","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/INF.0b013e31816a0e0a","article-title":"Outbreak of invasive group A streptococcal disease among children attending a day-care center.","volume":"27","author":"Aguero","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R18-20240429","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00431-010-1337-x","article-title":"Clinical characteristics of children with group A streptococcal toxic shock syndrome admitted to pediatric intensive care units.","volume":"170","author":"Rodr\u00edguez-Nu\u00f1ez","year":"2011","journal-title":"Eur J Pediatr"},{"key":"R19-20240429","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/INF.0b013e318195bb10","article-title":"Clinical and microbiologic characteristics of group A streptococcal necrotizing fasciitis in children.","volume":"28","author":"Minodier","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"R20-20240429","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.vaccine.2013.01.019","article-title":"Potential coverage of a multivalent M protein-based group A streptococcal vaccine.","volume":"31","author":"Dale","year":"2013","journal-title":"Vaccine"},{"key":"R21-20240429","doi-asserted-by":"crossref","first-page":"45","DOI":"10.7774\/cevr.2017.6.1.45","article-title":"Trivalent M-related protein as a component of next generation group A streptococcal vaccines.","volume":"6","author":"Courtney","year":"2017","journal-title":"Clin Exp Vaccine Res"},{"key":"R23-20240429","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s10096-012-1726-3","article-title":"Superantigen gene complement of Streptococcus pyogenes\u2013relationship with other typing methods and short-term stability.","volume":"32","author":"Fri\u00e3es","year":"2013","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R24-20240429","doi-asserted-by":"crossref","first-page":"734","DOI":"10.3201\/eid2204.151582","article-title":"Hypervirulent emm59 clone in invasive group A Streptococcus outbreak, Southwestern United States.","volume":"22","author":"Engelthaler","year":"2016","journal-title":"Emerg Infect Dis"},{"key":"R25-20240429","doi-asserted-by":"crossref","first-page":"30446","DOI":"10.2807\/1560-7917.ES.2017.22.3.30446","article-title":"Ongoing outbreak of invasive and non-invasive disease due to group A Streptococcus (GAS) type emm66 among homeless and people who inject drugs in England and Wales, January to December 2016.","volume":"22","author":"Bundle","year":"2017","journal-title":"Euro Surveill"},{"key":"R26-20240429","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1469-0691.2007.01706.x","article-title":"Paediatric varicella hospitalisations in France: a nationwide survey.","volume":"13","author":"Grimprel","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"R27-20240429","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0924-8579(01)00413-7","article-title":"Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci.","volume":"18","author":"Mascini","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"R28-20240429","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3389\/fpubh.2018.00059","article-title":"Prevalent emm types among invasive GAS in Europe and North America since year 2000.","volume":"6","author":"Gherardi","year":"2018","journal-title":"Front Public Health"},{"key":"R29-20240429","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1086\/653082","article-title":"Superantigen genes are more important than the emm type for the invasiveness of group A Streptococcus infection.","volume":"202","author":"Lintges","year":"2010","journal-title":"J Infect Dis"},{"key":"R30-20240429","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10096-017-2905-z","article-title":"Importance of whole genome sequencing for the assessment of outbreaks in diagnostic laboratories: analysis of a case series of invasive Streptococcus pyogenes infections.","volume":"36","author":"Tagini","year":"2017","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R31-20240429","doi-asserted-by":"crossref","first-page":"e1000832","DOI":"10.1371\/journal.ppat.1000832","article-title":"Highly frequent mutations in negative regulators of multiple virulence genes in group A streptococcal toxic shock syndrome isolates.","volume":"6","author":"Ikebe","year":"2010","journal-title":"PLoS Pathog"},{"key":"R32-20240429","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1128\/IAI.02892-14","article-title":"A truncation in the regulator RocA underlies heightened capsule expression in serotype M3 group A streptococci.","volume":"83","author":"Lynskey","year":"2015","journal-title":"Infect Immun"},{"issue":"pt 10","key":"R33-20240429","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1099\/jmm.0.2008\/001156-0","article-title":"Superantigen genes in group A streptococcal isolates and their relationship with emm types.","volume":"57","author":"Commons","year":"2008","journal-title":"J Med Microbiol"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002471","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T18:12:07Z","timestamp":1714414327000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002471","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]}}}